A softgel consists of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) drug or extract in the center.
PORTLAND, OREGON, UNITED STATES, June 25, 2023/EINPresswire.com/ — Enteric softgel capsules are a specialized form of oral medication delivery that offers unique advantages in certain situations. Unlike regular softgel capsules, enteric softgels are designed to resist the acidic environment of the stomach and dissolve in the alkaline environment of the small intestine. This delayed-release mechanism helps protect sensitive drugs or ingredients from degradation in the stomach, ensuring optimal absorption and bioavailability. The global enteric softgel capsules market was valued at $1,851 million in 2017, and is projected to reach $2,589 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 –
Enteric softgel capsules are commonly used for medications that may cause irritation or gastric side effects when released in the stomach. By bypassing the stomach and delivering the drug directly to the small intestine, enteric softgels can minimize gastrointestinal discomfort and enhance patient tolerance. This makes them particularly suitable for drugs that are prone to cause stomach upset, such as non-steroidal anti-inflammatory drugs (NSAIDs) or certain antibiotics.
Major market players covered in the report, such as –
Thermo Fisher Scientific, Inc. (Patheon),
Fuji Capsules Co., Ltd.,
Sirio Pharma Co., LTD,
Osmotica Pharmaceuticals plc. (Trigen Laboratories, Inc.),
NOW Foods Inc.
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝟐𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 –
Key Benefits for Stakeholders –
• The report provides quantitative analysis of market segments, current trends, strategies and potential of Enteric Softgel Capsules Market research to identify potential Enteric Softgel Capsules Market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter’s Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global Enteric Softgel Capsules Market analysis, key players, market segments, application areas and Market growth strategies.
The enteric coating of the softgel capsules is typically made of polymers that are resistant to acidic pH levels but dissolve rapidly in alkaline conditions. This coating serves as a barrier, preventing the drug from being released until it reaches the desired site of action. Once the enteric softgel capsule reaches the small intestine, the enteric coating dissolves, and the drug is then absorbed into the bloodstream, providing the intended therapeutic effect.
Enteric softgel capsules offer several advantages over other dosage forms, including improved drug stability, enhanced patient compliance, and reduced gastrointestinal side effects. By ensuring targeted drug delivery and protecting sensitive ingredients, they optimize the efficacy and safety of medications. However, it’s important to note that enteric softgel capsules should only be used as directed by healthcare professionals and are not suitable for all medications or conditions.
In summary, enteric softgel capsules are specialized oral drug delivery systems that release medication in the small intestine rather than the stomach. They provide a delayed-release mechanism that protects drugs from stomach acid and reduces gastric side effects. Enteric softgel capsules improve drug stability and patient comfort, making them a valuable option for certain medications that require specific site targeting or have a propensity to cause stomach irritation.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐈𝐧 𝐃𝐞𝐭𝐚𝐢𝐥 –
Frequently Asked Questions?
Q1. What is the total market value of Enteric Softgel Capsules Market report?
Q2. Which are the top companies holding the market share in Enteric Softgel Capsules Market?
Q3. Which are the largest regions for this Market?
Q4. What is the leading technology of Enteric Softgel Capsules Market?
Q5. What are the major drivers for this specific Market?
Q6. What are the upcoming key trends in the Enteric Softgel Capsules Market report?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Allied Analytics LLP
email us here
Article originally published on www.einpresswire.com as New Dynamics in The Enteric Softgel Capsules Market (CAGR of 6.3%)